Arvaya Healthcare (BOM:524723) Beta: -0.0312 (As of Jun. 30, 2026)


BOM:524723 Arvaya Healthcare Ltd BOM:524723
34 GF Score
Price ₹67.11
GF Value ₹48.85
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Arvaya Healthcare Beta?

Arvaya Healthcare BOM:524723 34 Beta is -0.0312 as of Jun. 30, 2026. GuruFocus rates BOM:524723 with a GF Score™ of 34/100 and a GF Value™ of ₹48.85 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-30), Arvaya Healthcare's Beta is -0.0312.


Arvaya Healthcare  (BOM:524723) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Arvaya Healthcare Beta Related Terms


Arvaya Healthcare Beta Historical Data

* Premium members only.

The historical data trend for Arvaya Healthcare's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arvaya Healthcare Beta Chart

Arvaya Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.02 -0.01 0.03 -0.01

Arvaya Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.02 -0.07 0.14 -0.01

BOM:524723 vs MCK, CAH, COR: Beta Comparison

For the Medical Distribution subindustry, Arvaya Healthcare's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arvaya Healthcare Beta vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Arvaya Healthcare's Beta distribution charts can be found below:

* The bar in red indicates where Arvaya Healthcare's Beta falls into.


BOM:524723
34GF Score
Arvaya Healthcare Ltd BOM:524723
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arvaya Healthcare Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.0312 mean?
Arvaya Healthcare (BOM:524723) has a Beta of -0.0312 as of Jun. 30, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Arvaya Healthcare and its competitors.
Is Arvaya Healthcare's Beta too high?
Arvaya Healthcare's current Beta is -0.0312. Overall, Arvaya Healthcare has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Arvaya Healthcare's Beta compare to MCK and CAH?
Arvaya Healthcare's Beta of -0.0312 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Distribution company?
A good Beta depends on the Medical Distribution industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Arvaya Healthcare and its competitors. Arvaya Healthcare's current Beta is -0.0312. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arvaya Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Arvaya Healthcare (BOM:524723) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹48.85, compared to a current price of ₹67.11 — trading 37.4% above its estimated fair value. The current Beta is -0.0312. Arvaya Healthcare's overall GF Score™ is 34/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Arvaya Healthcare (BOM:524723), the current Beta is -0.0312 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arvaya Healthcare (BOM:524723) Overvalued in 2026?

Based on GuruFocus' analysis, Arvaya Healthcare stock appears to be overvalued. The current stock price of ₹67.11 is trading 37.4% above its estimated GF Value™ of ₹48.85. GuruFocus considers Arvaya Healthcare to be Significantly Overvalued.

Key valuation signals for BOM:524723:

  • Beta: -0.0312
  • GF Value™: ₹48.85 vs. price of ₹67.11 (37.4% above fair value)
  • GF Score™: 34/100 with 7 warning signs

No single metric tells the full story. See the BOM:524723 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Arvaya Healthcare Business Description

Address G S Road, Nirvana Co Working spaces, Mezzanine Floor, Itag Plaza, ABC, Kamrup, Dispur, Gmc, Guwahati, AS, IND, 781005
Arvaya Healthcare Ltd is focused on developing an integrated healthcare platform in India that combines hospital services, diagnostics, wellness services, and digital health management solutions. Its operations include multi-specialty hospitals, a digital health platform for appointment booking and health record management, diagnostic services including laboratory testing and home sample collection, and wellness facilities offering preventive and recovery-focused programs.
34GF Score

Get the complete analysis for BOM:524723

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹67.11
Price
₹48.85
GF Value